Cystic fibrosis transmembrane conductance regulator potentiation as a therapeutic strategy for pulmonary edema: a proof-of-concept study in pigs
Objectives: To determine the feasibility of using a cystic fibrosis transmembrane
conductance regulator potentiator, ivacaftor (VX-770/Kalydeco, Vertex Pharmaceuticals …
conductance regulator potentiator, ivacaftor (VX-770/Kalydeco, Vertex Pharmaceuticals …
Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT
DF McAuley, JG Laffey, CM O'Kane… - Efficacy and …, 2018 - wrap.warwick.ac.uk
Background Acute lung injury is a common devastating clinical syndrome characterised by
life-threatening respiratory failure requiring mechanical ventilation and multiple organ …
life-threatening respiratory failure requiring mechanical ventilation and multiple organ …
[HTML][HTML] Adjunctive therapies during veno-venous extracorporeal membrane oxygenation
F Pappalardo, A Montisci - Journal of Thoracic Disease, 2018 - ncbi.nlm.nih.gov
Veno-venous extracorporeal membrane oxygenation (VV ECMO) restores gas exchanges in
severely hypoxemic patients. The need for adjunctive therapies usually originates either …
severely hypoxemic patients. The need for adjunctive therapies usually originates either …
Does salbutamol associated with increase in lactate levels in emergency department patients?
2. Method This is a retrospective cross-sectional study that was conducted at Dokuz Eylul
University Department of Emergency Medicine, which accepts approximately 135,000 …
University Department of Emergency Medicine, which accepts approximately 135,000 …
[PDF][PDF] Systemic and inhaled corticosteroids, with or without beta agonists, as adjuvant therapy in community acquired pneumonia.
SA Helgeson, JE Levitt, E Festic - 2020 - pdfs.semanticscholar.org
The aim is to provide a narrative review of the role of corticosteroids, with and without
inhaled beta agonist, in communityacquired pneumonia. Community and health-care …
inhaled beta agonist, in communityacquired pneumonia. Community and health-care …
Acute respiratory distress syndrome
P Lane, U O'Brien, MA Gooney, T Reid, AA Lash… - …, 2017 - journals.lww.com
AUTHOR INDEX Page 1 November/December 2005 297 2005 An K. See De Jong MMJ
Ankney N. See Gay SE Baas L. See Beery TA Beery TA, Baas LS, Matthews H, Burroughs J …
Ankney N. See Gay SE Baas L. See Beery TA Beery TA, Baas LS, Matthews H, Burroughs J …
[HTML][HTML] Ведение пациентов с острыми респираторными инфекциями на фоне хронической сердечно-сосудистой патологии. Клинические рекомендации …
АВ Горелов, АА Плоскирева… - … медицины и спорта, 2020 - cyberleninka.ru
Рецензенты: Малеев ВВ, академик РАН, д. м. н., профессор, Советник директора ФБУН
ЦНИИ Эпидемиологии Роспотребнадзора по научной работе; Петров ВА—д. м. н …
ЦНИИ Эпидемиологии Роспотребнадзора по научной работе; Петров ВА—д. м. н …
[PDF][PDF] Síndrome de dificultad respiratoria aguda (SDRA)
J Rae - 18vo World Congress of Anesthesiologists. https …, 2019 - resources.wfsahq.org
Descrito por primera vez en 1967, el SDRA es un síndrome de falla respiratoria y proxémica
asociada a edema pulmonar no cardiogénico. Es el resultado del daño de la inflamación …
asociada a edema pulmonar no cardiogénico. Es el resultado del daño de la inflamación …
Functional relevance of Na+-coupled neutral amino acid transporter SNAT2 as master regulator of alveolar homeostasis and its critical role in ARDS
S Weidenfeld - 2022 - refubium.fu-berlin.de
Acute respiratory distress syndrome (ARDS), a life-threatening disease, is the most frequent
cause of death in critical care medicine. Despite numerous clinical trials, effective …
cause of death in critical care medicine. Despite numerous clinical trials, effective …